Blog / Topics
Provenance, privacy and consent
31 guides, published between March 2026 and September 2026. Where did a record come from, who agreed to its use, and what happens when they change their mind?
Guides
- Onboarding Studio: what a zero-copy health data intake actually looks like
September 13, 2026
Most health data onboarding pipelines copy records into a new environment before scoring them. Onboarding Studio does not. It scores, validates, and governs data at the source, producing a DTI trust score and a hash-chained receipt without ever moving the underlying record. That distinction determines whether your AI pipeline meets regulatory scrutiny or fails it.
- Explainable data provenance: why health AI has to show where every record came from
September 12, 2026
Health AI systems that cannot trace every record back to its origin are making clinical decisions on faith. Explainable data provenance assigns a verifiable chain of custody to each data point before it enters a model, and the 25% weight provenance carries in the DTI framework reflects its foundational role. Without it, explainability stops at the model and never reaches the data.
- Trauma history data: the most sensitive SDOH dimension and its consent requirements
August 27, 2026
Adverse childhood experiences data is the most sensitive dimension of social determinants of health, yet most health AI systems treat it with the same consent architecture as food insecurity screening. ACE data consent requires trauma-informed protocols, granular disclosure controls, and trust scoring that reflects the unique re-traumatization risk embedded in every query. Without these safeguards, trauma history data becomes a liability that harms the people it was collected to help.
- Purpose limitation in health AI: why secondary use consent is not a catch-all
August 12, 2026
Secondary use consent does not cover purpose limitation. A patient who consents to data sharing for treatment does not consent to that same data training a sepsis prediction algorithm, feeding a payer risk model, or populating a pharma commercial dataset. Purpose limitation is a distinct legal and ethical constraint that broad consent language cannot absorb.
- When a patient revokes consent, what happens to the AI model?
August 11, 2026
When a patient withdraws consent, most health AI systems have no mechanism to propagate that revocation to downstream models already trained on the data. The gap between consent withdrawal and actual data removal creates legal exposure, trust erosion, and model integrity failures that compound across every system in the chain.
- Dynamic consent architectures: how real-time consent changes affect data trust
August 10, 2026
Most consent systems treat authorization as a one-time event. When a patient changes their consent preferences in real time, every downstream dataset, model, and analysis that depends on that data faces an immediate trust problem. Dynamic consent architecture solves the capture problem but creates a data integrity crisis that almost nobody is tracking.
- The consent layering problem: when downstream data use exceeds original consent
August 9, 2026
Most health data consent frameworks capture a single moment of agreement, then allow that data to flow through unlimited downstream uses. A 2023 ONC study found that 79% of patients did not know their clinical data had been shared with third parties for secondary purposes. Consent layering, the practice of stacking new data uses on top of original permissions, is the structural failure that erodes health data secondary use trust.
- Digital pathology image data trust: whole slide imaging provenance requirements
July 29, 2026
A single whole slide image can exceed 10 gigabytes and contain billions of pixels, yet most digital pathology AI pipelines have no formal method for verifying where that image came from, how it was scanned, or whether its metadata survived the transfer intact. Whole slide imaging provenance is the missing trust layer between the glass slide and the algorithm.
- Biobank sample provenance: genetic data trust requirements for research use
July 27, 2026
Biobank samples carry genetic data that can identify individuals, families, and entire ethnic populations. Without verified provenance, consent traceability, and chain of custody documentation, biobank data becomes a liability rather than an asset for genomic research. Sample provenance requirements are tightening across regulatory bodies, and the gap between what biobanks track and what research use demands is growing.
- Federated learning and health data trust: why model weights still carry privacy risk
July 10, 2026
Federated learning keeps raw health data local, but model weights transmitted between nodes still leak patient information. Gradient inversion attacks, membership inference, and property inference can reconstruct individual records from weight updates alone. The privacy promise of federated AI in healthcare requires more than architecture; it requires scored, governed data at the source.
- Differential privacy in healthcare data: what it actually protects and what it doesn't
July 9, 2026
Differential privacy adds mathematical noise to health datasets so that no single patient's record can be reverse-engineered from query results. But noise does not fix provenance failures, consent gaps, or the re-identification risks that arise when multiple de-identified datasets are linked. Understanding what differential privacy actually protects requires separating the math from the marketing.
- Re-identification risk: why HIPAA Safe Harbor is not sufficient for modern AI
May 12, 2026
HIPAA Safe Harbor removes 18 identifiers from health records, but modern AI can re-identify up to 99.98% of individuals using as few as 15 data attributes. The gap between what Safe Harbor protects and what AI can infer is the most dangerous blind spot in health data governance today.
- What the Change Healthcare breach taught us about health data infrastructure trust
May 11, 2026
The Change Healthcare breach exposed 100 million patient records and paralyzed claims processing for months. But the deeper failure was not the ransomware itself. It was the absence of any trust verification layer across health data infrastructure, meaning no one could confirm what data had been altered, accessed, or corrupted after the attack.
- The difference between data anonymization and data de-identification in healthcare
May 11, 2026
HIPAA defines two methods for de-identification, but neither method equals anonymization. The distinction determines whether health data can be re-linked to a patient, whether it qualifies for regulatory safe harbor, and whether AI models trained on it carry legal exposure. Most healthcare organizations conflate the two terms and absorb risk they never priced.
- Employer health data and the consent governance challenge
May 7, 2026
Employer wellness programs collect biometric screenings, mental health app usage, and claims data on millions of workers, yet most operate under consent frameworks designed for marketing opt-ins, not health data governance. The gap between what employees technically agree to and what they actually understand creates legal exposure, erodes trust, and poisons downstream data quality for any AI system trained on it.
- Consumer health data ownership: what the 21st Century Cures Act actually enables
May 6, 2026
The 21st Century Cures Act gave patients a legal right to access their electronic health data through standardized APIs. But access is not ownership. Without trust scoring, provenance tracking, and consent governance, the data patients receive is often incomplete, outdated, or unusable for the AI systems that need it most.
- IntegrityNet onboarding: what a zero-copy health data intake actually looks like
May 4, 2026
Most health data onboarding processes copy records into a new environment, creating compliance risk and provenance gaps before analysis even begins. IntegrityNet eliminates data movement entirely, scoring and cataloging EHR data in place through a zero-copy architecture that preserves chain of custody from the first connection. Here is what that process actually looks like, step by step.
- ConsentOS: what five-tier consent architecture looks like in practice
May 1, 2026
Most healthcare organizations treat consent as a single checkbox. A five-tier consent architecture separates identity verification, data use authorization, purpose-specific permissions, downstream sharing controls, and revocation rights into distinct, auditable layers. ConsentOS operationalizes all five tiers so every health data record carries machine-readable consent metadata before any AI model touches it.
- Glass Box vs Black Box: why health AI needs explainable data provenance
April 30, 2026
Most explainable AI frameworks explain model decisions but ignore whether the training data was trustworthy in the first place. Glass box AI in healthcare requires more than interpretable algorithms. It requires explainable data provenance, where every record carries a verified chain of custody before a model ever touches it.
- Zero-copy health data architecture: how trust does not require data movement
April 29, 2026
Most health data architectures assume that sharing data means moving it. Zero-copy architecture breaks that assumption by allowing queries to execute where data already lives, eliminating duplication and the trust violations that come with it. But zero-copy alone does not solve the trust problem unless every record queried carries a verifiable trust score.
- Federated health data networks and the trust problem they cannot avoid
April 28, 2026
Federated health data networks keep records behind institutional firewalls, but they do not solve the trust problem. Every node in a federation contributes data of unknown quality, unknown provenance, and unverified consent status. Without a trust layer underneath, federated learning in healthcare inherits every flaw of the data it never moves.
- AI explainability solves the wrong problem: why trusting a model output means nothing if the training data was never verified
April 28, 2026
Explainability techniques tell you why a model made a decision, but they cannot tell you whether the data behind that decision was accurate, consented, or even real. The AI industry has spent billions making outputs interpretable while ignoring the fact that 91% of health data quality issues originate before a model ever trains. Trusting a model's reasoning is meaningless if nobody verified the inputs.
- Genomic data trust: provenance requirements for precision medicine
April 26, 2026
Genomic data powers precision medicine, but fewer than 30% of clinical genomic datasets carry full provenance metadata. Without knowing where a variant call originated, how a sample was processed, and whether consent covers secondary AI use, precision medicine operates on assumptions rather than evidence. Genomic data trust requires provenance infrastructure that most health systems have not built.
- The chain of custody problem in health data: why provenance is the hardest dimension
April 25, 2026
Provenance carries the highest weight in the Data Trust Index for a reason: it is the dimension most likely to be broken, forged, or simply missing across health data systems. A single patient record can pass through 17 or more systems before reaching a decision point, and each handoff creates an opportunity for the chain of custody to fracture silently.
- What HIPAA does not tell you about data trust
April 24, 2026
HIPAA protects against unauthorized disclosure of health information, but it says nothing about whether that data is accurate, current, or trustworthy. The gap between HIPAA compliance and actual data trust is where health AI fails, clinical decisions go wrong, and patients lose confidence in the system.
- Mental health data: the most sensitive consent domain in healthcare AI
April 24, 2026
Mental health data carries legal, clinical, and social risks that no other healthcare data category matches. Federal law treats it differently, patients fear it differently, and AI systems trained on it fail differently. Behavioral health data governance requires a consent architecture that most health AI companies have not built.
- Pediatric health data governance: what is different about consent for minors
April 23, 2026
Children cannot consent for themselves, and their parents cannot consent forever. Pediatric health data governance sits in a legal and ethical gap that most health systems, AI developers, and researchers fail to address. The consequences show up in broken consent chains, unusable training data, and adolescents who avoid care entirely.
- VA health system data: the provenance challenge at scale
April 21, 2026
The VA health system holds records for over 9 million enrolled veterans, making it the largest integrated healthcare network in the United States. But integration on paper does not mean data provenance at scale. The ongoing Electronic Health Record Modernization (EHRM) program, workforce attrition, and legislative uncertainty are compounding a trust problem that no single technology migration can solve.
- Why consent governance fails in healthcare data and what fixes it
April 21, 2026
Patient consent in healthcare is still governed by static forms signed once and never revisited. Over 80% of patients report not understanding what they consented to, and most health systems have no mechanism to track consent status across data lifecycles. Fixing healthcare consent governance requires architecture, not just policy.
- Data provenance in healthcare AI: why chain of custody matters before training
April 20, 2026
Sixty-three percent of healthcare AI models retrained in 2024 cited data quality failures rooted in unknown or unverifiable origins. Before any model touches a health record, that record needs a documented chain of custody. Without provenance, AI training is guesswork with clinical consequences.
- The HIPAA Problem Health AI Companies Are Ignoring: Patient Consent Does Not Cover Model Training
March 31, 2026
When a patient signs a HIPAA notice at a hospital, they authorize the use of their data for treatment, payment, and healthcare operations. They do not authorize its use in training an AI model. Most health AI companies are building on a consent foundation that does not exist.